Ofir Bar is a Direct PhD candidate at Ben-Gurion University of the Negev. She studies immune-based approaches for breast cancer and investigates how positive neuroendocrine signals linked to laughter may shape anti-cancer immunity. She developed Wellnitor through Teva’s BioMix program- a wearable patch and AI concept for real-time stress and inflammation monitoring to help prevent stress-linked Crohn’s/IBD flares.
